Both epinephrine and norepinephrine enhance the process of fat mobilization. This property of promoting lipolysis has been observed both in vitro by demonstrating the release of free fatty acids (FFA) and glycerol from adipose tissue within the medium, and in vivo by the increase in the levels of plasma FFA in the fasted, resting individual (1-3 
Both epinephrine and norepinephrine enhance the process of fat mobilization. This property of promoting lipolysis has been observed both in vitro by demonstrating the release of free fatty acids (FFA) and glycerol from adipose tissue within the medium, and in vivo by the increase in the levels of plasma FFA in the fasted, resting individual (1) (2) (3) . It was the intent of this study to determine whether the property of lipolysis was a singular characteristic of epinephrine and norepinephrine or whether other catechols and other vasoactive substances also could promote fat mobilization. It 
RESULTS
The initial studies were directed at developing a "standardized" or "control" method of assay of compound activity. The first set of observations was made on 20 fasting subjects who were kept in the supine, resting position for the entire study, receiving an intravenous infusion of 0.9 per cent saline. The mean (± 1 SE) peak Figure 1 illustrates the presently formulated outline of the biogenesis and degradation of norepinephrine and epinephrine. It was the intent of this study to test as many of the compounds involved in the sequence of chemical events as were available. Of the six compounds actually assayed. neither the two before (dopamine and dopa 1) nor the four degradative products after (3,4-dihydroxy mandelic acid; 3-methoxy,4-hydroxy mandelic acid; normetanephrine; metanephrine) nor-1 a-Methyl-dopa was actually studied, since the addition (rather than any substitution) of a methyl function was not considered inhibiting to a fat mobilizing agent. hydroxyl (dopamine) also modified activity. The addition of two methyl groups to the carbon already bound to the amino nitrogen (isoproterenol) does not modify fat-mobilizing activity. These several structural alterations do not, however, completely remove the vasoactive property of these compounds (Table I) . Figures 1 and 2 have been drawn so as to emphasize the four chemical groups which must be present in relationship to the benzene ring to cause a fat-mobilizing response. The FFA activity of isoproternol, containing the four groups, should be noted, because it is a synthetic compound in which the structural alterations have resulted in changes in the specific cardiovascular effect, but in which the fat-mobilizing effect is still present. The studies of the vasoactive polypeptides were conducted in order to test whether the vascular effects were comparably separable from any lipolytic effects; the absence of any plasma FFA increase would indicate that such an independence of activity does exist. SUMMARY 1. The effect of the intravenous infusion of a series of catechol compounds and vasoactive polypeptides upon the plasma free fatty acid level of fasting, resting individuals was studied.
2. The presence of a benzene ring with two hydroxyl groups in the 3 and 4 position, a /3-carbon hydroxyl and an amino group attached to the a-carbon atom are the four concomitant chemical functions necessary for effective fat mobilizing property in man.
3. Although the polypeptides studied demonstrated vascular activity, no lipid-mobilizing effect was noted, further supporting the suggested specificity of the chemical structure necessary for fat mobilization.
